AstraZeneca

The World Needs New Antibiotics, but the Business Model Is Broken

New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link

1 year ago

Big Pharma Bets Big on China

China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link

2 years ago

FDA Approves First RSV Drug to Protect All Infants

While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the…

2 years ago

Unusual Call Option Trade in AstraZeneca (AZN) Worth $1,645.00K

On April 5, 2023 at 10:13:59 ET an unusually large $1,645.00K block of Call contracts in AstraZeneca (AZN) was sold,…

2 years ago

AstraZeneca : Lynparza Combination Improves PFS In Phase III Ovarian Cancer Trial

(RTTNews) - British drug major AstraZeneca Plc (AZN, AZN.L) said results from an interim analysis of the DUO-O Phase III…

2 years ago

Regeneron, Sanofi Look for Billions From COPD Drug

The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease.…

2 years ago